Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Skye Bioscience (SKYE)
NASDAQ:SKYE
Holding SKYE?
Track your performance easily
SKYE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.44 - $19.41
Previous Close$4.12
Volume119.78K
Average Volume (3M)320.30K
Market Cap
$124.99M
Enterprise Value$57.77M
Total Cash (Recent Filing)$67.41M
Total Debt (Recent Filing)$190.99K
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Nov 07, 2024EPS Estimate
-$0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.84
Shares Outstanding30,338,290
10 Day Avg. Volume183,775
30 Day Avg. Volume320,298
Standard Deviation0.48
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)1.71
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda1.77
Forecast
1Y Price Target
$18.00Price Target Upside336.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Skye Bioscience News
PremiumCompany Announcements
Skye Bioscience Reports Progress in Obesity Drug Trials
PremiumCompany Announcements
Skye Bioscience Appoints New Chairman for Strategic Growth
PremiumCompany Announcements
Skye Bioscience Approves Incentive Plan Amendments and Leadership ChangesRisk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SKYE FAQ
What was Skye Bioscience’s price range in the past 12 months?
Skye Bioscience lowest stock price was $1.44 and its highest was $19.41 in the past 12 months.
What is Skye Bioscience’s market cap?
Currently, no data Available
When is Skye Bioscience’s upcoming earnings report date?
Skye Bioscience’s upcoming earnings report date is Nov 07, 2024 which is 19 days ago.
How were Skye Bioscience’s earnings last quarter?
Skye Bioscience released its earnings results on Aug 09, 2024. The company reported -$0.2 earnings per share for the quarter, missing the consensus estimate of -$0.195 by -$0.005.
Is Skye Bioscience overvalued?
According to Wall Street analysts Skye Bioscience’s price is currently Undervalued.
Does Skye Bioscience pay dividends?
Skye Bioscience does not currently pay dividends.
What is Skye Bioscience’s EPS estimate?
Skye Bioscience’s EPS estimate is -$0.25.
How many shares outstanding does Skye Bioscience have?
Skye Bioscience has 30,338,290 shares outstanding.
What happened to Skye Bioscience’s price movement after its last earnings report?
Skye Bioscience reported an EPS of -$0.2 in its last earnings report, missing expectations of -$0.195. Following the earnings report the stock price went up 4.963%.
Which hedge fund is a major shareholder of Skye Bioscience?
Among the largest hedge funds holding Skye Bioscience’s share is Versant Venture Management, LLC. It holds Skye Bioscience’s shares valued at 8M.
---
Skye Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$18.00 (336.89% Upside)
$18.00 (336.89% Upside)
Blogger Sentiment
Bullish
SKYE Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 919.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 3.6%
Last 30 Days ▲ 4.8%
Last 30 Days ▲ 4.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
171.05%
12-Months-Change
Fundamentals
Return on Equity
-54.82%
Trailing 12-Months
Asset Growth
422.52%
Trailing 12-Months
Company Description
Skye Bioscience
Emerald Bioscience, Inc. engages on discovering, developing and commercializing new chemical entities from a class of chemically diverse compounds called cannabinoids. The company was founded on March 16, 2011 and is headquartered in Long Beach, CA.
---
SKYE Earnings Call
Q3 2024
0:00 / 0:00
---
SKYE Stock 12 Month Forecast
Average Price Target
$18.00
▲(336.89% Upside)
Technical Analysis
Enveric Biosciences
―
Cyclacel Pharmaceuticals
―
Actinium Pharmaceuticals
―
Kura Oncology
―
Best Analysts Covering SKYE
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-19.23%
reiterated a buy rating 13 days ago
Copying Albert Lowe's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -19.23% per trade.
---